{"id":"corticosteroids","brandName":"Corticosteroids","genericName":"corticosteroids","companyId":"pfizer","companyName":"Pfizer Inc.","phase":"discontinued","status":"discontinued","modality":"","aliases":[],"developmentCodes":[],"firstApprovalDate":null,"firstApprovalCountry":null,"aiSummary":"Corticosteroids are a broad class of anti-inflammatory and immunosuppressant medications that mimic cortisol, a natural hormone produced by the adrenal glands. They work by binding to glucocorticoid receptors in the cytoplasm, translocating to the nucleus, and modulating gene expression to suppress pro-inflammatory cytokines, reduce immune cell activation, and decrease vascular permeability. While Pfizer does not manufacture a branded corticosteroid product currently in active development, corticosteroids remain foundational therapies across multiple therapeutic areas including rheumatoid arthritis, asthma, COPD, allergic rhinitis, and transplant rejection prophylaxis, as evidenced by 50 active clinical trials spanning Phase 1–4 and observational studies. The class demonstrates clinical differentiation through formulation innovations (inhaled, topical, injectable) and combination therapies that optimize efficacy while minimizing systemic exposure and adverse effects. Corticosteroids represent a multi-billion-dollar global market with generic competition across most indications; clinical development continues to focus on steroid-sparing strategies and novel delivery mechanisms. The pipeline reflects integration of corticosteroids as adjunctive or backbone therapy in modern immunology and respiratory medicine rather than standalone development.","enrichmentLevel":3,"visitCount":9,"mechanism":{},"administration":{},"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":["NCT04259138","NCT01621880","NCT07329946","NCT00711555","NCT01448213","NCT02909335","NCT07335679","NCT05906433","NCT00933023","NCT00862979","NCT02175771","NCT02062463","NCT00159263","NCT03291314","NCT00801632","NCT00980707","NCT05294744","NCT01697098","NCT00798616","NCT04237987","NCT02907671","NCT00213421","NCT00597857","NCT03005236","NCT02701634","NCT03345407","NCT02182492","NCT02229136","NCT02255032","NCT05638932","NCT06851845","NCT01397201","NCT04074187","NCT00002881","NCT01960530","NCT01850771","NCT01830699","NCT01336413","NCT05933382","NCT07431424","NCT00826462","NCT06952686","NCT01868061","NCT06980896","NCT01336296","NCT07378761","NCT02740543","NCT06274996","NCT02777268","NCT00307658"],"indications":{"approved":[],"offLabel":[],"pipeline":[]},"commercial":null,"patents":[],"timeline":[],"rwe":[],"competitors":[],"ownershipHistory":[],"trialDetails":[{"nctId":"NCT04259138","phase":"Phase 4","title":"VERDICT: In actiVE Ulcerative Colitis, a RanDomIzed Controlled Trial for Determination of the Optimal Treatment Target","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alimentiv Inc.","isPivotal":false,"enrollment":672,"indication":"Colitis, Ulcerative","completionDate":"2026-03-31"},{"nctId":"NCT01621880","phase":"Phase 2","title":"Effect of Bevacizumab on Radiation-induced Brain Necrosis in Patients With Nasopharyngeal Carcinoma","status":"COMPLETED","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","isPivotal":false,"enrollment":112,"indication":"Nasopharyngeal Carcinoma, Adverse Effect of Radiation Therapy","completionDate":"2015-12"},{"nctId":"NCT07329946","phase":"NA","title":"Erdosteine Effect on Oxidative Stress, Inflammatory Response and Immune Modulation in Patients With COPD. A Single Center, Open Label, Double Arm, Controlled, 4-week, Explorative, ex Vivo Study.\"","status":"NOT_YET_RECRUITING","sponsor":"Pierachille Santus, MD, PhD","isPivotal":false,"enrollment":30,"indication":"COPD","completionDate":"2027-12-31"},{"nctId":"NCT00711555","phase":"Phase 2","title":"An Open Label Phase II Study of Aprepitant for Multi-day Moderately-high to Highly Emetogenic Chemotherapy Regimens","status":"COMPLETED","sponsor":"University of Illinois at Chicago","isPivotal":false,"enrollment":22,"indication":"Nausea, Vomiting","completionDate":"2009-01"},{"nctId":"NCT01448213","phase":"Phase 2","title":"Comparison Of Two Corticosteroid Dosing Regimens For Prevention Of Corneal Transplant Rejection Episodes After Descemet's Membrane Endothelial Keratoplasty","status":"COMPLETED","sponsor":"Price Vision Group","isPivotal":false,"enrollment":264,"indication":"Fuchs' Dystrophy, Bullous Keratopathy","completionDate":"2014-01"},{"nctId":"NCT02909335","phase":"Phase 3","title":"De Novo Everolimus Versus Tacrolimus in Combination With Mofetil Mycophenolate and Low Dose Corticosteroids to Reduce Tacrolimus Induced Nephrotoxicity in Liver Transplantation: a Prospective, Multice","status":"WITHDRAWN","sponsor":"Rennes University Hospital","isPivotal":true,"enrollment":0,"indication":"Liver Transplantation","completionDate":"2021-11"},{"nctId":"NCT07335679","phase":"N/A","title":"Characterization of the Strasbourg Cohort of Patients With Adrenal Cortex Carcinoma","status":"RECRUITING","sponsor":"University Hospital, Strasbourg, France","isPivotal":false,"enrollment":60,"indication":"Adrenal Cortical Carcinoma","completionDate":"2027-06-10"},{"nctId":"NCT05906433","phase":"Phase 1","title":"Optimal Anesthetic for Corticosteroid Injections for Knee Osteoarthritis.","status":"RECRUITING","sponsor":"Foundation for Orthopaedic Research and Education","isPivotal":false,"enrollment":75,"indication":"Knee Osteoarthritis","completionDate":"2025-12-01"},{"nctId":"NCT00933023","phase":"Phase 4","title":"A Randomised Controlled Trial of Mild Versus Potent Topical Corticosteroids as Primary Treatment for Non-retractile Foreskin in Children.","status":"WITHDRAWN","sponsor":"Chelsea and Westminster NHS Foundation Trust","isPivotal":false,"enrollment":0,"indication":"Phimosis","completionDate":"2009-09"},{"nctId":"NCT00862979","phase":"Phase 4","title":"A Multi-center, Randomized, Open-label, Parallel Group Study Investigating the Renal Tolerability, Efficacy and Safety of a CNI-free Regimen (Everolimus and MPA) Versus a CNI-regimen With Everolimus i","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","isPivotal":false,"enrollment":162,"indication":"Heart Transplantation","completionDate":"2017-03-06"},{"nctId":"NCT02175771","phase":"Phase 3","title":"A 26-Week Open-Label Study to Assess the Long-Term Safety of Fluticasone Propionate Multidose Dry Powder Inhaler and Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler in Patients 12 Years","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","isPivotal":true,"enrollment":758,"indication":"Persistent Asthma","completionDate":"2015-07"},{"nctId":"NCT02062463","phase":"Phase 3","title":"A 12-Week, Randomized, Open-Label, Parallel-Group Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® (160/4.5 and 320/9 mcg) as Compared With SYMBICORT® TURBOH","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","isPivotal":true,"enrollment":485,"indication":"Asthma","completionDate":"2015-03-13"},{"nctId":"NCT00159263","phase":"NA","title":"Effect of Symbicort on GR (Glucocorticoid Receptor) Translocation in Induced Sputum in Comparison With Budesonide, Formoterol and Placebo. A Single Dose Exploratory Study in Patients With Mild Asthma","status":"COMPLETED","sponsor":"Imperial College London","isPivotal":false,"enrollment":10,"indication":"Asthma","completionDate":"2006-11"},{"nctId":"NCT03291314","phase":"Phase 2","title":"Phase II Clinical Trial on the Combination of Avelumab and Axitinib for the Treatment of Patients With Recurrent Glioblastoma","status":"COMPLETED","sponsor":"Universitair Ziekenhuis Brussel","isPivotal":false,"enrollment":52,"indication":"Recurrent Glioblastoma (WHO-Grade IV Glioma)","completionDate":"2019-01-01"},{"nctId":"NCT00801632","phase":"Phase 2","title":"Renal Allograft Tolerance Through Mixed Chimerism","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","isPivotal":false,"enrollment":5,"indication":"Kidney Transplantation, Kidney Failure, Chronic","completionDate":"2014-11"},{"nctId":"NCT00980707","phase":"Phase 4","title":"Utility of Versican and Hyaluronan Measurement in Induced Sputum as Biomarker of Asthma","status":"COMPLETED","sponsor":"Associated Scientists to Help Minimize Allergies","isPivotal":false,"enrollment":10,"indication":"Allergic Asthma","completionDate":"2010-11"},{"nctId":"NCT05294744","phase":"NA","title":"Utility of the Use of N-acetylcysteine Associated With Conventional Treatment in Patients With Severe Acute Alcoholic Hepatitis (Maddrey> 32)","status":"RECRUITING","sponsor":"Bioaraba Health Research Institute","isPivotal":false,"enrollment":390,"indication":"Alcoholic Hepatitis","completionDate":"2026-12"},{"nctId":"NCT01697098","phase":"Phase 2","title":"Dexamethasone Dosing Interval: 12 or 24 Hours Apart? A Randomized,Clinical Trial","status":"COMPLETED","sponsor":"Assiut University","isPivotal":false,"enrollment":200,"indication":"Prematurity","completionDate":"2012-08"},{"nctId":"NCT00798616","phase":"NA","title":"Are Steroids Efficacious in Hospitalized Patients With Bronchiolitis Who Show an Objective Clinical Improvement After Albuterol (\"Albuterol Responders\")?","status":"WITHDRAWN","sponsor":"University Hospitals Cleveland Medical Center","isPivotal":false,"enrollment":0,"indication":"Bronchiolitis","completionDate":""},{"nctId":"NCT04237987","phase":"Phase 2","title":"A Randomized Controlled Trial to Evaluate the Efficacy and Safety of Low-dose Interleukin-2 in Combination With Standard Therapy Compared to Standard Therapy Alone in Adults With Active Idiopathic Inf","status":"UNKNOWN","sponsor":"Peking University People's Hospital","isPivotal":false,"enrollment":20,"indication":"Inflammatory Myopathy","completionDate":"2021-04-08"},{"nctId":"NCT02907671","phase":"NA","title":"Effectiveness of Ultrasound Guided Corticoanesthetic Injection in Carpal Tunnel Syndrome Comparing Two Different Injection Sites","status":"UNKNOWN","sponsor":"Rehabilitace MUDr. Hasan Mezian s.r.o.","isPivotal":false,"enrollment":40,"indication":"Carpal Tunnel Syndrome","completionDate":"2018-12"},{"nctId":"NCT00213421","phase":"N/A","title":"","status":"COMPLETED","sponsor":"University Hospital, Rouen","isPivotal":false,"enrollment":330,"indication":"Bullous Pemphigoid","completionDate":"2008-11"},{"nctId":"NCT00597857","phase":"NA","title":"Prevention of PTSD With Early Hydrocortisone Treatment: Pilot","status":"UNKNOWN","sponsor":"Kent State University","isPivotal":false,"enrollment":65,"indication":"Posttraumatic Stress Disorder","completionDate":"2009-11"},{"nctId":"NCT03005236","phase":"Phase 4","title":"AGe-adapted Benefits of Envarsus Versus Twice-daily Tacrolimus ImmunosuppressioN druGs After Kidney Transplantation (AGEING) - a Feasibility Study","status":"UNKNOWN","sponsor":"University Hospital Birmingham NHS Foundation Trust","isPivotal":false,"enrollment":40,"indication":"Kidney Transplant Failure and Rejection","completionDate":"2019-10"},{"nctId":"NCT02701634","phase":"Phase 2","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Tolerability of Entospletinib, a Selective SYK Inhibitor, in Combination With Systemic Corticosteroids as First","status":"TERMINATED","sponsor":"Gilead Sciences","isPivotal":false,"enrollment":66,"indication":"Chronic Graft Versus Host Disease","completionDate":"2018-03-06"},{"nctId":"NCT03345407","phase":"Phase 2","title":"A Phase IIb, Randomized (Stratified), Double-Blind (Sponsor Open), Parallel-Group, Placebo-Controlled, Dose-Finding Study of Nemiralisib (GSK2269557) Added to Standard of Care (SoC) Versus SoC Alone i","status":"TERMINATED","sponsor":"GlaxoSmithKline","isPivotal":false,"enrollment":943,"indication":"Pulmonary Disease, Chronic Obstructive","completionDate":"2019-01-10"},{"nctId":"NCT02182492","phase":"NA","title":"Comparison of Different Efficacy of Macrolide and Glucocorticoid in the Treatment of Chronic Rhinosinusitis Patients After Endoscopic Sinus Surgery","status":"COMPLETED","sponsor":"Zheng Liu","isPivotal":false,"enrollment":187,"indication":"Chronic Rhinosinusitis, Endoscopic Sinus Surgery","completionDate":"2016-06"},{"nctId":"NCT02229136","phase":"Phase 2","title":"Evaluation of Miracle Mouthwash (MMW) Plus Hydrocortisone and Prednisolone Mouth Rinse as Prophylaxis for Everolimus-Associated Stomatitis","status":"COMPLETED","sponsor":"US Oncology Research","isPivotal":false,"enrollment":104,"indication":"Stomatitis, Oral Mucositis","completionDate":"2022-11"},{"nctId":"NCT02255032","phase":"Phase 2","title":"A Randomized, Masked, Multicenter Study to Assess the Safety and Efficacy of CLS-TA, Triamcinolone Acetonide Injectable Suspension in the Treatment of Subjects With Macular Edema Following Uveitis","status":"COMPLETED","sponsor":"Clearside Biomedical, Inc.","isPivotal":false,"enrollment":22,"indication":"Uveitis, Macular Edema","completionDate":"2016-01"},{"nctId":"NCT05638932","phase":"N/A","title":"Methodologies for Observational Studies Comparing Inpatient COVID-19 Treatments: IL-6 Receptor Inhibitors and JAK Inhibitors for Hospitalized COVID-19 Patients Receiving Corticosteroid Therapy","status":"COMPLETED","sponsor":"Aetion, Inc.","isPivotal":false,"enrollment":1442,"indication":"COVID-19","completionDate":"2023-09-25"},{"nctId":"NCT06851845","phase":"N/A","title":"Clinical Outcomes of C3 Glomerulopathy and IC-MPGN in Russia: Hybrid Retrospective - Prospective Study","status":"NOT_YET_RECRUITING","sponsor":"Novartis Pharmaceuticals","isPivotal":false,"enrollment":100,"indication":"Kidney Diseases","completionDate":"2028-02-01"},{"nctId":"NCT01397201","phase":"Phase 2","title":"A Randomised, Double-blind, Double-dummy, Placebo-controlled, Parallel-group Study to Assess and Compare Efficacy and Safety of an 8-week Treatment With BI 54903 at Doses of 45.5, 90.9 and 181.8 mcg b","status":"TERMINATED","sponsor":"Boehringer Ingelheim","isPivotal":false,"enrollment":30,"indication":"Asthma","completionDate":"2011-12-23"},{"nctId":"NCT04074187","phase":"Phase 2","title":"An Open-label Multicenter Trial to Study the Efficacy and Safety of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura","status":"COMPLETED","sponsor":"Sanofi","isPivotal":true,"enrollment":21,"indication":"Thrombotic Thrombocytopenic Purpura","completionDate":"2021-05-19"},{"nctId":"NCT00002881","phase":"Phase 3","title":"PHASE III TRIAL OF ORCHIECTOMY/LHRH ANALOG + FLUTAMIDE + SURAMIN + HYDROCORTISONE VS ORCHIECTOMY/LHRH ANALOG + FLUTAMIDE IN PATIENTS WITH METASTATIC PROSTATE CANCER","status":"COMPLETED","sponsor":"Eastern Cooperative Oncology Group","isPivotal":true,"enrollment":0,"indication":"Prostate Cancer","completionDate":""},{"nctId":"NCT01960530","phase":"Phase 1","title":"An Open Label, Partially Randomised, Single Dose, Crossover Study to Evaluate the PK, Oral Bioavailability and Relationship to Metabolic Parameters of Hydrocortisone and Infacort® in Healthy Adult Mal","status":"COMPLETED","sponsor":"Neurocrine UK Limited","isPivotal":false,"enrollment":14,"indication":"Adrenal Insufficiency","completionDate":"2014-11"},{"nctId":"NCT01850771","phase":"NA","title":"A Single-Blinded, Randomized Controlled Trial of Regenexx™ PL-Disc Versus Steroid Epidurals for Treatment of Lumbar Radiculopathy","status":"TERMINATED","sponsor":"Regenexx, LLC","isPivotal":false,"enrollment":8,"indication":"Radiculopathy, Herniated Disc","completionDate":"2016-05"},{"nctId":"NCT01830699","phase":"NA","title":"Rilonacept (Arcalyst ®) in the Treatment of Subacromial Bursitis","status":"COMPLETED","sponsor":"Keesler Air Force Base Medical Center","isPivotal":false,"enrollment":33,"indication":"Subacromial Bursitis","completionDate":"2014-03"},{"nctId":"NCT01336413","phase":"Phase 2","title":"Neuroactive Steroids and TBI in OEF/OIF Veterans","status":"COMPLETED","sponsor":"VA Office of Research and Development","isPivotal":false,"enrollment":53,"indication":"Brain Injuries, Traumatic","completionDate":"2016-02"},{"nctId":"NCT05933382","phase":"NA","title":"Investigation of the Effects of Mobilization With Movement Technique and Corticosteroid Injection on Pain, Functionality, and Proprioception in Rotator Cuff Lesions","status":"COMPLETED","sponsor":"Istanbul Medipol University Hospital","isPivotal":false,"enrollment":60,"indication":"Rotator Cuff Tears","completionDate":"2024-02-10"},{"nctId":"NCT07431424","phase":"NA","title":"A Prospective Comparative Study of Ultrasound-Guided Radiofrequency Ablation and Steroid Injection in Individuals With Lower Extremity Amputation and Symptomatic Stump Neuroma","status":"COMPLETED","sponsor":"Gaziler Physical Medicine and Rehabilitation Education and Research Hospital","isPivotal":false,"enrollment":26,"indication":"Stump Neuroma, Residual Limb Pain","completionDate":"2024-02-04"},{"nctId":"NCT00826462","phase":"Phase 4","title":"Physiotherapy Alone, in Combination With Corticosteroid Injection or Wait-and-see for Acute Lateral Epicondylitis in General Practice: a Randomised, Placebo-controlled Study With 12 Months Follow-up","status":"COMPLETED","sponsor":"University of Oslo","isPivotal":false,"enrollment":177,"indication":"Tennis Elbow, Epicondylitis, Lateral Humeral","completionDate":"2013-06"},{"nctId":"NCT06952686","phase":"Phase 3","title":"A Seamless Phase 1/3, Multicenter, Single Dose Systemic Gene Transfer Study to Evaluate the Safety, Tolerability, and Efficacy of SRP-9005 in Limb Girdle Muscular Dystrophy Type 2C/R5 Subjects (COMPAS","status":"WITHDRAWN","sponsor":"Sarepta Therapeutics, Inc.","isPivotal":true,"enrollment":0,"indication":"Muscular Dystrophies, Limb-Girdle","completionDate":"2032-03-30"},{"nctId":"NCT01868061","phase":"Phase 3","title":"A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second C","status":"COMPLETED","sponsor":"Hoffmann-La Roche","isPivotal":true,"enrollment":1068,"indication":"Asthma","completionDate":"2017-01-02"},{"nctId":"NCT06980896","phase":"N/A","title":"Exploratory Pathophysiological Study on the Association Between Physical Performance and Biomarkers of Oxidative Stress and Low-Grade Inflammation in Elderly Patients","status":"NOT_YET_RECRUITING","sponsor":"Nantes University Hospital","isPivotal":false,"enrollment":30,"indication":"Inflammation, Oxydative Stress","completionDate":"2027-05-01"},{"nctId":"NCT01336296","phase":"Phase 4","title":"A 12-month, Prospective, Randomized, Dual Center, Open Label Pilot Study to Evaluate the Safety and Efficacy of Myfortic® (Mycophenolic Acid) Loading Regimens in Combination With Thymoglobulin® [Anti-","status":"COMPLETED","sponsor":"University of Cincinnati","isPivotal":false,"enrollment":61,"indication":"Kidney Transplant Recipients","completionDate":"2014-04"},{"nctId":"NCT07378761","phase":"Phase 2","title":"Efficacy of Ursodeoxycholic Acid Versus Corticosteroids for the Treatment of Cholestatic Hepatitis Secondary to Immunotherapy: A Multicenter, Controlled, Randomized, Open Trial","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Montpellier","isPivotal":false,"enrollment":94,"indication":"Immune-Mediated Cholestasis","completionDate":"2028-08"},{"nctId":"NCT02740543","phase":"Phase 2","title":"Biomarkers of Irritant-Induced and Allergic Asthma","status":"COMPLETED","sponsor":"NYU Langone Health","isPivotal":false,"enrollment":18,"indication":"Asthma","completionDate":"2019-10-23"},{"nctId":"NCT06274996","phase":"N/A","title":"A Retrospective Analysis of the Efficacy and Safety of Upadacitinib in the Treatment of Inflammatory Bowel Disease","status":"COMPLETED","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","isPivotal":false,"enrollment":81,"indication":"Inflammatory Bowel Diseases","completionDate":"2023-12-31"},{"nctId":"NCT02777268","phase":"Phase 1","title":"A Single Centre, Open Label, Randomised, Crossover Study in Dexamethasone-suppressed Healthy Adult Male Volunteers to Compare the Pharmacokinetics of Infacort® Versus Immediate-release Hydrocortisone ","status":"COMPLETED","sponsor":"Neurocrine UK Limited","isPivotal":false,"enrollment":16,"indication":"Healthy Subjects","completionDate":"2013-09"},{"nctId":"NCT00307658","phase":"Phase 3","title":"Intravenous Immunoglobulin After Relapse in Vasculitis (Microscopic Polyangiitis, Wegener's Granulomatosis and SHURG-STRAUSS Syndrome) During and After Corticosteroids and Immunosuppressant Therapies ","status":"TERMINATED","sponsor":"Assistance Publique - Hôpitaux de Paris","isPivotal":true,"enrollment":40,"indication":"ANCA + Vasculitides Relapsing Either Under Corticosteroid, and Immunosuppressant Therapies or After One Year","completionDate":"2006-07"}],"genericFilers":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"labelChanges":[],"nice":null,"revenue":null,"trialStats":{"total":43,"withResults":18},"crossReferences":{"chemblId":"CHEMBL509924","pubchemSID":"53790464"},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}